Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed in ECOG PS 3 Stage IV Non-squamous NSCLC
NCT02426658Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- May 2015
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by Wake Forest University Health Sciences. Started May 2015; status: completed.
02
Drugs
pemetrexed
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT02426658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02426658.